 "Prosthetic & therapeutic robotics market to reach $ 3.6 bn in 2025")
Prosthetic and therapeutic robotic devices will grow into a $1.9 billion and $1.7 billion market by 2025 respectively, as an aging population demands better quality of life and superior performance, according to Lux Research.
Predictably, the largest markets for the prosthetic robotics - devices such as bionic arms and legs - will reside in developed countries in Europe and the US, but China will comprise nearly one-third of the total 2025 market, more than any other country.
Therapeutic robotics - devices that help a range of conditions from strokes to spinal cord injuries - are less sensitive to the availability of insurance reimbursement, so most of this market will be from sales to centralised rehabilitation centres.
“Robotics is rapidly entering the future of healthcare as a tool that will enable more advanced and personalised care for millions of patients. As longevity increases, more people are demanding better rehabilitative care. The rapid rise in patient numbers degrades medical providers’ ability and further stresses the need for more robotic technologies to assist in treatment,” said Maryanna Saenko, Lux Research analyst and lead author of the report titled, ‘Automating the road to recovery: How the rehabilitation robotics market is changing the future of health care’.
Global life expectancy has risen to 78.7 years, compared to 75.4 in 1990. Additionally, the number of people aged 65 or over is projected to rise to nearly two billion in 2050. This will raise the population of those with debilitating diseases requiring rehabilitative care.
According to Lux Research, the number of patients needing rehabilitative robotics is on the rise not only because people are living longer but also because incidences of conditions like stroke are increasing, and life expectancy of those affected is growing. As per the American Heart Association, the number of stroke survivors is to rise by 68 percent by 2050, from the current 665,000. Similarly, survivors of spinal cord injuries are growing.
Lux Research predicts huge opportunity for device integrators. The therapeutics market lacks existing infrastructure, making it a fertile ground for new technologies despite challenges arising from medical reimbursement. “An even larger opportunity exists for device integrators because profit margins are significantly higher than for makers of finished products in the medical devices industry,” said Lux Research in a press release.
Predictably, the largest markets for the prosthetic robotics - devices such as bionic arms and legs - will reside in developed countries in Europe and the US, but China will comprise nearly one-third of the total 2025 market, more than any other country.
Therapeutic robotics - devices that help a range of conditions from strokes to spinal cord injuries - are less sensitive to the availability of insurance reimbursement, so most of this market will be from sales to centralised rehabilitation centres.
“Robotics is rapidly entering the future of healthcare as a tool that will enable more advanced and personalised care for millions of patients. As longevity increases, more people are demanding better rehabilitative care. The rapid rise in patient numbers degrades medical providers’ ability and further stresses the need for more robotic technologies to assist in treatment,” said Maryanna Saenko, Lux Research analyst and lead author of the report titled, ‘Automating the road to recovery: How the rehabilitation robotics market is changing the future of health care’.
Global life expectancy has risen to 78.7 years, compared to 75.4 in 1990. Additionally, the number of people aged 65 or over is projected to rise to nearly two billion in 2050. This will raise the population of those with debilitating diseases requiring rehabilitative care.
According to Lux Research, the number of patients needing rehabilitative robotics is on the rise not only because people are living longer but also because incidences of conditions like stroke are increasing, and life expectancy of those affected is growing. As per the American Heart Association, the number of stroke survivors is to rise by 68 percent by 2050, from the current 665,000. Similarly, survivors of spinal cord injuries are growing.
Lux Research predicts huge opportunity for device integrators. The therapeutics market lacks existing infrastructure, making it a fertile ground for new technologies despite challenges arising from medical reimbursement. “An even larger opportunity exists for device integrators because profit margins are significantly higher than for makers of finished products in the medical devices industry,” said Lux Research in a press release.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%